Phase 4
Completed N=100
Interest in the Use of Dressings With Honey for Wound Healing After Excision of Pilonidal Cyst
Pilonidal Cysts
Source: ClinicalTrials.gov NCT02485860 ↗
Enrolled (actual)
100
Serious AEs
1.0%
Results posted
Oct 2023
Primary outcomePrimary: Healing Time — 78; 61 Days — p=0.094
◆ Published Evidence
Emerging
4citations · ~1 / year
The value of honey dressings in pilonidal cyst healing: a prospective randomized single-center trial.
Summary
The management of pilonidal cysts is a skin excision and under deep skin. Scarring requires regular dressings (daily for 15 days and then every 48 hours) until complete healing. This healing is obtained on average in 68 days. Some patients have difficulties in healing with a final healing achieved on average in 95 days. Some teams use honey to promote wound cavitary wounds (wound infection, pressure ulcers, varicose wound). The acceleration of wound healing is due to antibacterial properties and hyperosmolarity to reduce secretions. ) The use of honey in pilonidal cysts is not evaluated and may accelerate healing.
Linked Publications
-
The value of honey dressings in pilonidal cyst healing: a prospective randomized single-center trial.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Healing Time |
78; 61 | 0.094 |
Eligibility Criteria
Inclusion Criteria
- Cavity Wound to 6 weeks of a pilonidal cyst excision
- Bloodless wound
- Pilonidal cyst not recurred
- Age : 18 years and older
- Signature of informed consent
- In the capacity to understand the study
Exclusion Criteria
- Bleeding wound
- Refused to participate in Protocol
- Patient immunocompromised
- Recurrent pilonidal cyst
- Patients on long-term corticosteroid
- Patient deprived of liberty, under guardianship
- Patient unable to understand the study
- Allergy or hypersensitivity to honey
- Allergy Or hypersensitivity to hyaluronic acid
- Allergy or hypersensitivity to guar gum
- Allergy or hypersensitivity to pectin
- Known allergy to propolis (potentially present in honey)
- Sensitivity to zinc oxide
- Sensitivity known dressings used in this trial or any component
- Diabetes Non-insulin or insulin
Data sourced from ClinicalTrials.gov (NCT02485860) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.